# Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans

> **NCT04565067** · — · ACTIVE_NOT_RECRUITING · sponsor: **National Institute on Aging (NIA)** · enrollment: 83 (actual)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04565067
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-22
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-09-30
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565067, "Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04565067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*